|
US2016152979A1
|
|
Novel compounds
|
|
US2016208247A1
|
|
Methods of use of sphingolipid polyalkylamine oligonucleotide compounds
|
|
CN105452465A
|
|
Sphingolipid-polyalkylamine-oligonucleotide compounds
|
|
CN104379745A
|
|
Therapeutic oligonucleotides comprising pyrazolotriazine nucleotide analogues
|
|
EP2797632A1
|
|
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
|
WO2006092795A2
|
|
Oligoribonucleotides and methods of use thereof for treatment of ocular scarring and other fibrotic conditions
|
|
EP1012268A1
|
|
Ires sequences with high translational efficiency and expression vectors containing the sequence
|
|
CA2271068A1
|
|
Method for identifying translationally regulated genes
|
